1. Engelbrektson AL, Korzenik JR, Pittler A, Sanders ME,
Klaenhammer TR, Leyer G, Kitts CL. 2009. Probiotics to
minimize the disruption of faecal microbiota in healthy
subjects undergoing antibiotic therapy. J Med Microbiol.
58: 663-670.
2. Ringel Y, Palsson OS, Leyer G, Causey S,Yeskel SE, Faber
SM, Ringel-Kulka T. 2008. Probiotic bacteria Lactobacillus
acidophilus NCFMRand Bifi dobacterium lactis Bi-07R
improve symptoms of bloating patients with functional
bowel disorders (FBD). Gastroenterology. 134(4 Suppl.
1):A549.
3. Faber SM. 2000. Treatment of abnormal gut fl ora improves
symptoms in patients with irritable bowel syndrome.
Am J Gastroenterol. 95: 2533.
4. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand
AC.2009. Probiotic effects on cold and infl uenza-like symptom
incidence and duration in children. Pediatrics 124:
e172-e179
5. Gobel R, Larsen N, Molgaard C, Jakobsen M, Michaelsen
KF. 2010. Probiotics to young children with atopic dermatitis:
A randomized placebo-controlled trial. Int J Prob
Preb. 5: 53-60.
6. Reid G. 2000. Investigation of the properties of Lactobacillus
acidophilus NCFMR as a possible probiotic for the
urogenital tract. International Dairy Journal 10: 415-419.